SCHEMBL19957205

SCHEMBL19957205

COc1cc2nccc(Oc3ccc(Nc4c(NCc5cccnc5)c(=O)c4=O)c(Cl)c3)c2cc1C=O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SRC P12931 3/20 0.44
PGK1 P00558 2/20 0.43
EGFR P00533 1/20 0.43
ERBB2 P04626 1/20 0.43
KDR P35968 9/20 0.42
MET P08581 4/20 0.41
PDGFRA P16234 3/20 0.41
RIPK2 O43353 2/20 0.41
STK10 O94804 2/20 0.41
ABL1 P00519 2/20 0.41
RET P07949 2/20 0.41
PDGFRB P09619 2/20 0.41
KIT P10721 2/20 0.41
BCR P11274 2/20 0.41
FGFR1 P11362 2/20 0.41
FLT1 P17948 2/20 0.41
FLT4 P35916 2/20 0.41
SLC6A3 Q01959 2/20 0.41
DDR1 Q08345 2/20 0.41
MAP4K2 Q12851 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19956952 0.87 KDR (0.55) EGFRERBB2KDRMETPDGFRA
SCHEMBL19957195 0.85 SRC (0.46) SRCEGFRKDRMETPDGFRA
SCHEMBL19957133 0.81 FGFR4 (0.52) SRCEGFRKDRMETPDGFRA
SCHEMBL19957408 0.80 KDR (0.41) SRCEGFRKDRMETPDGFRA
SCHEMBL19957371 0.79 KDR (0.58) EGFRKDRMETPDGFRARIPK2
SCHEMBL19957068 0.78 RET (0.58) SRCEGFRKDRMETPDGFRA
SCHEMBL19956954 0.76 KDR (0.58) EGFRKDRMETPDGFRARIPK2
SCHEMBL20927399 0.76 RET (0.57) SRCEGFRKDRMETPDGFRA
SCHEMBL19957317 0.75 KDR (0.59) EGFRKDRMETPDGFRARIPK2
SCHEMBL19957176 0.74 KDR (0.51) SRCEGFRKDRMETPDGFRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3293177-A1 TYROSINE KINASE INHIBITOR AND PHARMACEUTICAL COMPOSITION COMPRISING SAME GUANGDONG ZHONGSHENG PHARMACEUTICAL CO., LTD (CN) 2018-03-14 EP disclosed